Riverside Sells GTI Diagnostics
Private equity firm Riverside Co. sold its in vitro diagnostics company to listed, California-based Gen-Probe for $53 million, earning the sponsor a 2.6x cash-on-cash return and a gross IRR of 46 percent. The private equity firm has maintained a busy pace of LBOs throughout the second half of 2010.
16 December 2010•3 mins read
